← Leaderboards
Jayakar V Nayak
Stanford University
$2,392,495
Attributed
$2,392,495
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $529.7K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,392,495 · 1
By mechanism
R01$2,392,495 · 1
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Sriram Vaidyanathan$1,080,072
- Kelley Yan$6,007,087
- Philip A Beachy$22,123,478
- Irving Lerner Weissman$56,491,773
- Mark Mercola$44,191,191
Others in their field
Other Emerging Leaders on “Cell Transplantation”
- Bronwen Shaw · Medical College Of Wisconsin$24,584,971
- Geoffrey Roger Hill · Fred Hutchinson Cancer Center$14,037,213
- Raghuveera Yaramolu · Eminent Services Corporation$9,791,923
- William H. Peranteau · Children'S Hosp Of Philadelphia$7,624,302
- Benjamin J Burwitz · Oregon Health & Science University$7,204,087
- Mehmet Toner · University Of Minnesota-Twin Cities$6,312,212
Research focus
Cell TransplantationChloridesAirway EpitheliumCell TherapyCell SurvivalChimerismAutologousAnimal ModelAnionsCell Replacement TherapyCellsAirway DiseaseArchitectureBehavior In VitroBicarbonatesBiocompatible MaterialsBiological ModelsBioluminescence ImagingCell BehaviorCell CountCell Differentiation ProcessCell FractionAnion Transport ProteinsClustered Regularly Interspaced Short Palindromic Repeats
Grant awards (5)
Optimizing Surgical Transplant of CFTR Gene-Corrected Human Basal Stem Cells to the Upper Airway$464,728
R01 · FY2025 · HL · contact PI
Optimizing Surgical Transplant of CFTR Gene-Corrected Human Basal Stem Cells to the Upper Airway$458,061
R01 · FY2024 · HL · contact PI
Optimizing Surgical Transplant of CFTR Gene-Corrected Human Basal Stem Cells to the Upper Airway$469,923
R01 · FY2023 · HL · contact PI
Optimizing Surgical Transplant of CFTR Gene-Corrected Human Basal Stem Cells to the Upper Airway$470,100
R01 · FY2022 · HL · contact PI
Optimizing Surgical Transplant of CFTR Gene-Corrected Human Basal Stem Cells to the Upper Airway$529,683
R01 · FY2021 · HL · contact PI